Evaxion Biotech A/S (NASDAQ:EVAX) Stock Tanks Following First Quarter Earnings

May 12, 2022

On Wednesday, Evaxion Biotech A/S (NASDAQ:EVAX) was in the news after the company announced its financial results for the first fiscal quarter. The innovative company, which is involved in developed artificial intelligence based immunotherapies, could not impress investors however and the stock tanked by as much as 15% for the day. Trading Data On Wednesday, EVAX stock moved down 15.11% to $1.91 with more than 287K shares, compared to its…

Read More >>